ArticleScientific reports2025
A brain cancer microtissue model for studying tumor cell and neural cell interactions.
Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- 3D cortical microtissue with innate microglia for studying real-time cell behavior across maturation and inflammatory response.bioRxiv : the preprint server for biology · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
Abstract
Glioblastoma (GBM) is an aggressive brain cancer with a poor prognosis and is challenging to study due to its high degree of inter- and intra-tumoral heterogeneity and complex tumor microenvironment. Current in vitro models of GBM, including patient-derived organoids and 2D and 3D cell cultures can recapitulate aspects of the GBM biology, but interactions with normal cells of the central nervous system remain challenging to model. Herein, we introduce a new 3D biomimetic brain cancer microtissue (BCM) developed by co-culturing rat cortical microtissues with rat glioma cell lines. Leveraging this model, we have characterized glioma cell motility, invasiveness, and interactions with neurons, astrocytes, and microglia. GBM cell behavior in the BCM model is consistent with that observed in vivo. This robust and versatile platform will enable future high-throughput therapeutic screening and detailed insights into primary glioma biology and potentially other brain tumors and cancers that metastasize to the brain.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.